Ibex AI: A Pathologists’ Perspective (USCAP 2025)

In this video, Dr. Mahul Amin of Labcorp and University of Tennessee provides an overview of the role AI is currently playing in the primary diagnosis of prostate cancer, and the value it brings to pathologists, physicians and patients. He also shares new data from robust precision and clinical validation studies conducted at multiple US and European laboratories as part of the FDA clearance, demonstrating AI’s clinical utility and benefits compared with the current standard of care.

Share this article:

Subscribe to our newsletter:

By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?
How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News
The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics
Scroll to Top
IBEX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.